Phase 3 Epilepsy Trial, Recruiting (NCT06262594)

Phase 3 Epilepsy Trial, Recruiting NCT06262594 Sponsor: University of Manitoba Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06262594 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have epilepsy that is focused in one part of the brain and is linked to sleep (known as sleep-related focal epilepsy)
You are using an effective form of contraception (birth control)

Who may not be able to join:

Your epilepsy medication has been changed in the month before or during the study
You are currently taking certain other medications that were restricted in a previous related study called SUNRISE1 (confirm with trial site)
You have liver problems or liver disease
You are pregnant or currently breastfeeding
You have breathing difficulties or problems with your lungs or airways
You have a history of complex behaviours during sleep (such as sleepwalking or acting out during sleep)
You have a rare inherited condition affecting how your body processes certain sugars, such as galactosemia or glucose-galactose malabsorption
You have a history of dependence on, tolerance to, or misuse of medications or substances, including issues with rebound insomnia
You have a psychiatric condition involving unusual thoughts or behavioural changes, depression, or thoughts of harming yourself
You have been diagnosed with narcolepsy (a condition causing sudden sleep attacks)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 204-787-2684

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06262594

Sponsor: University of Manitoba

Phase: Phase 3

Status: Recruiting

Condition: Epilepsy

Trial contact: 204-787-2684

More information: https://clinicaltrials.gov/study/NCT06262594

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have epilepsy that is focused in one part of the brain and is linked to sleep (known as sleep-related focal epilepsy)
You are using an effective form of contraception (birth control)

Who may not be able to join:

Your epilepsy medication has been changed in the month before or during the study
You are currently taking certain other medications that were restricted in a previous related study called SUNRISE1 (confirm with trial site)
You have liver problems or liver disease
You are pregnant or currently breastfeeding
You have breathing difficulties or problems with your lungs or airways
You have a history of complex behaviours during sleep (such as sleepwalking or acting out during sleep)
You have a rare inherited condition affecting how your body processes certain sugars, such as galactosemia or glucose-galactose malabsorption
You have a history of dependence on, tolerance to, or misuse of medications or substances, including issues with rebound insomnia
You have a psychiatric condition involving unusual thoughts or behavioural changes, depression, or thoughts of harming yourself
You have been diagnosed with narcolepsy (a condition causing sudden sleep attacks)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

University of Manitoba

Registry

ClinicalTrials.gov

Start date

29 October 2024

Est. completion

18 April 2026

Where this trial is recruiting

🇨🇦 Canada 🇺🇸 United States

Primary endpoints

WASO

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov